DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
Latest Information Update: 18 Apr 2025
At a glance
- Drugs Temozolomide (Primary) ; Varlilumab (Primary) ; Dendritic cells; Diphtheria-tetanus vaccine
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms DERIVe
Most Recent Events
- 15 Apr 2025 Planned End Date changed from 1 Mar 2025 to 1 Mar 2026.
- 15 Apr 2025 Planned primary completion date changed from 1 Mar 2025 to 1 Mar 2026.
- 17 Jul 2023 Status changed from recruiting to active, no longer recruiting.